Trial intelligence / Profile preview

Testosterone undecanoate plus nutritional supplement for reducing hospitalizations in undernourished older adults

ACTRN12610000356066Phase 4Completed

Sponsor
University of Adelaide
Start
May 2010
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of testosterone undecanoate in Malnutrition, Undernutrition and Fragility (2 arms), sponsored by University of Adelaide. Primary endpoints: Days in hospital and number of hospital admissions and Quality-adjusted life years. Started May 2010; status: completed.

02

Drugs

testosterone undecanoate
03

Conditions

MalnutritionUndernutritionFragility

Beyond the preview

Go deeper on ACTRN12610000356066.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12610000356066.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call